Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
5 Years
4.3
65.75%
40%
—
-98.70%
60%
—
5 Years
Score4.3
Net Growth65.75%
Net Trend40%
Net Income Consistency—
Rev Growth-98.70%
Rev Trend60%
Revenue Consistency—
Seres Therapeutics Inc fundamental performance
Between 2020 and 2025, revenue declined from $ 33M to $ 789K and net income went from -$ 89M to $ 5M. Revenue increased in 3 of those 5 years; net income in 2.
Between 2015 and 2025, revenue grew from $ 0.00 to $ 789K and net income went from -$ 54M to $ 5M. Revenue increased in 6 of those 10 years; net income in 5.
Seres Therapeutics Inc currently holds a 5-year HDB Score of 4.3 out of 10. How the HDB Score is calculated.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 4.72 | — |
1 Year2025-08-12 | $ 15.44 | -69.43% |
5 Years2021-08-12 | $ 136.00 | -96.53% |
10 Years2016-08-12 | $ 210.60 | -97.76% |
All Time2015-06-26 | $ 1.03K | -99.54% |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | 10 Years2016-08-12 | All Time2015-06-26 |
|---|---|---|---|---|---|
| Price | $ 4.72 | $ 15.44 | $ 136.00 | $ 210.60 | $ 1.03K |
| Return | — | -69.43% | -96.53% | -97.76% | -99.54% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 1M | -$ 22M | $ 15M |
| 2025 | $ 789K | $ 5M | $ 45M |
| 2024 | $ 0.00 | -$ 146M | $ 30M |
| 2023 | $ 126M | -$ 113M | $ 127M |
| 2022 | $ 7M | -$ 250M | $ 181M |
| 2021 | $ 144M | -$ 65M | $ 290M |
| 2020 | $ 33M | -$ 89M | $ 253M |
| 2019 | $ 34M | -$ 70M | $ 94M |
| 2018 | $ 28M | -$ 98M | $ 85M |
| 2017 | $ 32M | -$ 89M | $ 149M |
| 2016 | $ 21M | -$ 91M | $ 193M |
| IPO2015 | $ 0.00 | -$ 54M | $ 205M |
Explore beyond MCRB
You're looking at Seres Therapeutics Inc. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
